UNITED STATES OF AMERICA
before the
SECURITIES AND EXCHANGE COMMISSION
SECURITIES EXCHANGE ACT OF 1934
Release No. 77999 / June 7, 2016
Admin. Proc. File No. 3-17144

In the Matter of
MED-ZONE BIOTECHNOLOGIES ACQUISITION, INC.,
and
MILLENNIUM DIRECT, INC.

NOTICE THAT INITIAL DECISION HAS BECOME FINAL
The time for filing a petition for review of the initial decision in this proceeding has
expired. No such petition has been filed by Med-Zone Biotechnologies Acquisition, Inc., or
Millennium Direct, Inc., and the Commission has not chosen to review the decision on its own
initiative.
Accordingly, notice is hereby given, pursuant to Rule 360(d) of the Commission's Rules
of Practice,1 that the initial decision of the administrative law judge has become the final
decision of the Commission with respect to Med-Zone Biotechnologies Acquisition, Inc., and
Millennium Direct, Inc. 2 The order contained in that decision is hereby declared effective. The
initial decision ordered that, pursuant to Section 12(j) of the Securities Exchange Act of 1934,
the registrations of each class of registered securities of Respondents Med-Zone Biotechnologies
Acquisition, Inc., and Millennium Direct, Inc., are revoked.
For the Commission, by the Office of the General Counsel, pursuant to delegated
authority.

Brent J. Fields
Secretary

1
2

17 C.F.R. ยง 201.360(d).

Map IV Acquisition, Inc., Med-Zone Biotechnologies Acquisition, Inc., and Millennium
Direct, Inc., Initial Decision Release No. 1002 (Apr. 18, 2016), 113 SEC Docket 19, 2016 WL
1554846. The Central Index Key numbers are: 1294604 for Med-Zone Biotechnologies
Acquisition, Inc.; and 1114835 for Millennium Direct, Inc.

